Search results
Results from the WOW.Com Content Network
Power Driver: EZ-IO By Arrow Teleflex. The EZ-IO device is a small device that works like a traditional drill and drill bit, consisting of a reusable, battery-powered driver and disposable, hollow IO needle. [15] A trigger allows for the IO needle to enter the bone marrow space at a preset length without any pressure being applied. [16] In the ...
In 2001, Vidacare Corporation was established to bring this technology platform to market. In 2004, Vidacare received its first U.S. Food and Drug Administration (FDA) clearance for the EZ-IO Intraosseous Infusion System – the first battery-powered device to establish immediate vascular access using the IO space. [5]
IO intraosseous infusion access kit. This may come in the form of a B.I.G device or more commonly the EZ IO Drill. Historically the FAST 1 Kit has been used to gain IO access with this becoming less popular as technology develops. Hemorrhage (blood loss) Control. CAT, SOFT-T or improvised tourniquets.
For premium support please call: 800-290-4726 more ways to reach us
In December 2013, Teleflex completed the acquisition of Vidacare Corporation, integrating Vidacare's intraosseous EZ-IO and OnControl medical devices into Teleflex's Arrow product line. [13] [14] On September 5, 2017, Teleflex announced that it had entered into a definitive agreement to acquire NeoTract in a transaction valued at up to $1.1B USD.
Sortable table Abbreviation Meaning 131 I or I131: iodine-131 (aka radioactive iodine or radioiodine) : IA: intra-arterial: intra-articular: IAA: insulin autoantibody IABP: intra-aortic balloon pump
Global Medical Device Nomenclature (GMDN) is a system of internationally agreed generic descriptors used to identify all medical device products. This nomenclature is a naming system for products which include those used for the diagnosis, prevention, monitoring, treatment or alleviation of disease or injury in humans.
The Unique Device Identification (UDI) System is intended to assign a unique identifier to medical devices within the United States, Europe, China, South Korea, Saudi Arabia and Taiwan. [1] It was signed into law in the US on September 27, 2007, as part of the Food and Drug Administration Amendments Act (Section 226) of 2007.